Nasdaq Video Interview: Gary Steele, President & CEO, Landec Corporation (LNDC)
NEW YORK, Jun 11, 2010 (GlobeNewswire via COMTEX) --Veteran business journalist Jill Bennett joins Gary Steele, President & CEO, Landec Corporation (LNDC) to discuss the company's industry, strategy, financials and positioning.
Click here to view video:
About Gary T. Steele:
Georgia Tech, BS 1970 Stanford University, MBA 1975
Gary Steele is the President, CEO and Chairman of Landec Corporation, a publicly traded materials science company in Menlo Park, California since 1991. Landec Corporation develops and markets patented polymer products for food, agricultural, medical device and licensed partner applications. Landec had revenues of over $235 million in fiscal year 2009 and the Company has been profitable since 2003. Landec recently acquired Lifecore Biomedical, a biomaterials company in Chaska, Minnesota.
Prior to his employment at Landec, Gary was President and CEO of Molecular Devices Corporation in Sunnyvale, California from 1985 to 1991 and before that he was Vice President of Product Development at Genentech Corp., a biotechnology company in So. San Francisco, California from 1981 to 1985. After receiving his MBA from Stanford University in 1975, Gary worked as Senior Manager at McKinsey & Co., a management consulting firm in San Francisco, California.
About Landec Corporation:
Headquartered in Menlo Park, California, Landec is a materials science company, leveraging its capability in polymer science and bio-application development in order to commercialize new products within a variety of life science fields, including food, agricultural, personal care and medical device applications. With its Intelimer® polymers, Landec is able to customize its proprietary polymer materials for each application through the manipulation of their unique controlled release, temperature activation and/or biocompatibility properties. Landec's subsidiary, Apio Inc., has leveraged Landec's BreatheWay® membrane to become the leader in U.S. fresh-cut specialty vegetables. Landec Ag offers a full solution of seed coatings and enhancements that work with the latest genetic technologies to drive continuous improvements in crop yield. Landec has also commercialized dozens of personal care and adhesive products through its long-standing partner relationships. With its recent acquisition of Lifecore Biomedical, Landec is now a leading supplier of premium hyaluronan-based biomaterials for the medical and veterinary markets. Hyaluronic acid (HA) is naturally present in the skin, cartilage and fluid of humans and provides lubricating, connective and shock absorbing functions in both joints and soft tissue. Landec's Lifecore subsidiary is the leading supplier of HA to ophthalmology companies.
For more information on the opportunity to have your CEO discuss your company, please call NASDAQ CEO Signature Series, 978/461-3141.
This news release was distributed by GlobeNewswire, www.globenewswire.com
SOURCE: NASDAQ CEO Signature Series; Landec Corporation
The NASDAQ CEO Signature Series logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4839